Abstract
The risk of glioma has consistently been shown to be increased twofold in relatives of patients with primary brain tumors (PBT). A recent genome-wide linkage study of glioma families provided evidence for a disease locus on 17q12-21.32, with the possibility of four additional risk loci at 6p22.3, 12p13.33-12.1, 17q22-23.2, and 18q23. To identify the underlying genetic variants responsible for the linkage signals, we compared the genotype frequencies of 5,122 SNPs mapping to these five regions in 88 glioma cases with and 1,100 cases without a family history of PBT (discovery study). An additional series of 84 familial and 903 non-familial cases were used to replicate associations. In the discovery study, 12 SNPs showed significant associations with family history of PBT (P < 0.001). In the replication study, two of the 12 SNPs were confirmed: 12p13.33-12.1 PRMT8 rs17780102 (P = 0.031) and 17q12-21.32 SPOP rs650461 (P = 0.025). In the combined analysis of discovery and replication studies, the strongest associations were attained at four SNPs: 12p13.33-12.1 PRMT8 rs17780102 (P = 0.0001), SOX5 rs7305773 (P = 0.0001) and STKY1 rs2418087 (P = 0.0003), and 17q12-21.32 SPOP rs6504618 (P = 0.0006). Further, a significant gene-dosage effect was found for increased risk of family history of PBT with these four SNPs in the combined data set (P trend <1.0 × 10−8). The results support the linkage finding that some loci in the 12p13.33-12.1 and 17q12-q21.32 may contribute to gliomagenesis and suggest potential target genes underscoring linkage signals.
Similar content being viewed by others
Abbreviations
- PBT:
-
Primary brain tumor
- SNP:
-
Single nucleotide polymorphism
- GWA:
-
Genome-wide association
- LD:
-
Linkage disequilibrium
- LOD:
-
Logarithm (base 10) of odds
- OR:
-
Odds ratio
- CI:
-
95 % confidence interval
References
Akaike H (1974) A new look at the statistical model identification. IEEE Trans Autom Control 19:716–723
Bondy ML, Lustbader ED, Buffler PA, Schull WJ, Hardy RJ, Strong LC (1991) Genetic epidemiology of childhood brain tumors. Genet Epidemiol 8(4):253–267. doi:10.1002/gepi.1370080406
Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il’yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113(7 Suppl):1953–1968. doi:10.1002/cncr.23741
Cardis E, Richardson L, Deltour I, Armstrong B, Feychting M, Johansen C, Kilkenny M, McKinney P, Modan B, Sadetzki S, Schuz J, Swerdlow A, Vrijheid M, Auvinen A, Berg G, Blettner M, Bowman J, Brown J, Chetrit A, Christensen HC, Cook A, Hepworth S, Giles G, Hours M, Iavarone I, Jarus-Hakak A, Klaeboe L, Krewski D, Lagorio S, Lonn S, Mann S, McBride M, Muir K, Nadon L, Parent ME, Pearce N, Salminen T, Schoemaker M, Schlehofer B, Siemiatycki J, Taki M, Takebayashi T, Tynes T, van Tongeren M, Vecchia P, Wiart J, Woodward A, Yamaguchi N (2007) The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol 22(9):647–664. doi:10.1007/s10654-007-9152-z
Dahmane N, Sanchez P, Gitton Y, Palma V, Sun T, Beyna M, Weiner H, Ruiz i Altaba A (2001) The Sonic Hedgehog–Gli pathway regulates dorsal brain growth and tumorigenesis. Development 128(24):5201–5212
Dahmen RP, Koch A, Denkhaus D, Tonn JC, Sorensen N, Berthold F, Behrens J, Birchmeier W, Wiestler OD, Pietsch T (2001) Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 61(19):7039–7043
Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S, Hirohashi S (1998) Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res 58(16):3526–3528
Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86(21):1600–1608
Hemminki K, Li X (2003) Familial risks in nervous system tumors. Cancer Epidemiol Biomark Prev 12(11 Pt 1):1137–1142
Inestrosa NC, Arenas E (2010) Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci 11(2):77–86. doi:10.1038/nrn2755
Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Shapiro WR, Selker RG, Fine HA, Black PM, Loeffler JS, Linet MS (2001) Cellular-telephone use and brain tumors. New Engl J Med 344(2):79–86. doi:10.1056/NEJM200101113440201
Jackson KA, Oprea G, Handy J, Kimbro KS (2009) Aberrant STYK1 expression in ovarian cancer tissues and cell lines. J Ovarian Res 2(1):15. doi:10.1186/1757-2215-2-15
Kirikoshi H, Inoue S, Sekihara H, Katoh M (2001) Expression of WNT10A in human cancer. Int J Oncol 19(5):997–1001
Kondoh T, Kobayashi D, Tsuji N, Kuribayashi K, Watanabe N (2009) Overexpression of serine threonine tyrosine kinase 1/novel oncogene with kinase domain mRNA in patients with acute leukemia. Exp Hematol 37(7):824–830. doi:10.1016/j.exphem.2009.04.010
Kyritsis AP, Bondy ML, Rao JS, Sioka C (2010) Inherited predisposition to glioma. Neuro Oncol 12(1):104–113. doi:10.1093/neuonc/nop011
Lee J, Sayegh J, Daniel J, Clarke S, Bedford MT (2005) PRMT8, a new membrane-bound tissue-specific member of the protein arginine methyltransferase family. J Biol Chem 280(38):32890–32896. doi:10.1074/jbc.M506944200
Lewontin RC (1988) On measures of gametic disequilibrium. Genetics 120(3):849–852
Liu L, Yu XZ, Li TS, Song LX, Chen PL, Suo TL, Li YH, Wang SD, Chen Y, Ren YM, Zhang SP, Chang ZJ, Fu XY (2004) A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice. Cancer Res 64(10):3491–3499. doi:10.1158/0008-5472.CAN-03-2106
Liu J, Ghanim M, Xue L, Brown CD, Iossifov I, Angeletti C, Hua S, Negre N, Ludwig M, Stricker T, Al-Ahmadie HA, Tretiakova M, Camp RL, Perera-Alberto M, Rimm DL, Xu T, Rzhetsky A, White KP (2009a) Analysis of Drosophila segmentation network identifies a JNK pathway factor overexpressed in kidney cancer. Science 323(5918):1218–1222. doi:10.1126/science.1157669
Liu Y, Scheurer ME, El-Zein R, Cao Y, Do KA, Gilbert M, Aldape KD, Wei Q, Etzel C, Bondy ML (2009b) Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomark Prev 18(1):204–214. doi:18/1/20410.1158/1055-9965.EPI-08-0632
Liu Y, Shete S, Hosking F, Robertson L, Houlston R, Bondy M (2010) Genetic advances in glioma: susceptibility genes and networks. Curr Opin Genet Dev 20(3):239–244. doi:10.1016/j.gde.2010.02.001
Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, Murata M, Shimano T, Nakamura Y (1998) Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 58(12):2524–2527
Moriai R, Kobayashi D, Amachika T, Tsuji N, Watanabe N (2006) Diagnostic relevance of overexpressed NOK mRNA in breast cancer. Anticancer Res 26(6C):4969–4973
Qian J, Jiang Z, Li M, Heaphy P, Liu YH, Shackleford GM (2003) Mouse Wnt9b transforming activity, tissue-specific expression, and evolution. Genomics 81(1):34–46 (pii:S0888754302000125)
Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70(2):425–434
Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, Hoang-Xuan K, El Hallani S, Idbaih A, Zelenika D, Andersson U, Henriksson R, Bergenheim AT, Feychting M, Lonn S, Ahlbom A, Schramm J, Linnebank M, Hemminki K, Kumar R, Hepworth SJ, Price A, Armstrong G, Liu Y, Gu X, Yu R, Lau C, Schoemaker M, Muir K, Swerdlow A, Lathrop M, Bondy M, Houlston RS (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41(8):899–904. doi:10.1038/ng.407
Shete S, Lau CC, Houlston RS, Claus EB, Barnholtz-Sloan J, Lai R, Il’yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, Yang P, Vick NA, Wrensch M, Davis FG, McCarthy BJ, Leung EH, Davis C, Cheng R, Hosking FJ, Armstrong GN, Liu Y, Yu RK, Henriksson R, Melin BS, Bondy ML (2011) Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Res 71(24):7568–7575. doi:10.1158/0008-5472.CAN-11-0013
Smolich BD, McMahon JA, McMahon AP, Papkoff J (1993) Wnt family proteins are secreted and associated with the cell surface. Mol Biol Cell 4(12):1267–1275
Tchougounova E, Jiang Y, Brasater D, Lindberg N, Kastemar M, Asplund A, Westermark B, Uhrbom L (2009) Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence. Oncogene 28(12):1537–1548. doi:10.1038/onc.2009.9
Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96(6):434–442
Wakefield J (2007) A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am J Hum Genet 81(2):208–227. doi:10.1086/519024
Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492–507. doi:10.1056/NEJMra0708126
Wrensch M, Lee M, Miike R, Newman B, Barger G, Davis R, Wiencke J, Neuhaus J (1997) Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol 145(7):581–593
Zurawel RH, Chiappa SA, Allen C, Raffel C (1998) Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res 58(5):896–899
Acknowledgments
This work was supported by National Institutes of Health (5R01 CA119215, 5R01 CA070917 and R01CA52689). Additional support was provided by the American Brain Tumor Association, The National Brain Tumor Society, the Tug McGraw Foundation and the Wellcome Trust who provided funding for the parent GWAS. The authors acknowledge the input of the Gliogene External Advisory Committee. For more information about the Gliogene Consortium, please refer to the following Web site http://www.gliogene.org.
Conflict of interest
None declared.
Author information
Authors and Affiliations
Consortia
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Liu, Y., Melin, B.S., Rajaraman, P. et al. Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma. Hum Genet 131, 1507–1517 (2012). https://doi.org/10.1007/s00439-012-1187-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-012-1187-x